Email updates

Keep up to date with the latest news and content from AGP and BioMed Central.

This article is part of the supplement: International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour

Open Access Open Badges Poster presentation

Standardized low-resolution brain electromagnetic tomography (sLORETA) in the prediction of response to cholinesterase inhibitors in patients with Alzheimer's disease

Martin Brunovsky123*, Vladimir Krajca3, Frantiska Diblikova13, Ales Bartos124, Lucie Zavesicka12 and Milos Matousek1

  • * Corresponding author: Martin Brunovsky

Author Affiliations

1 Prague Psychiatric Center, Prague, Czech Republic

2 3rd Medical Faculty, Charles University, Prague, Czech Republic

3 Department of Neurology, Faculty Hospital Bulovka, Prague, Czech Republic

4 Department of Neurology, Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic

For all author emails, please log on.

Annals of General Psychiatry 2008, 7(Suppl 1):S277  doi:10.1186/1744-859X-7-S1-S277

The electronic version of this article is the complete one and can be found online at:

Published:17 April 2008

© 2008 Brunovsky et al.; licensee BioMed Central Ltd.


We tried to identify subgroup of patients with Alzheimer's disease (AD) benefiting from cholinesterase inhibitors (ChEI) treatment using standardized low-resolution brain electromagnetic tomography (sLORETA) [1], which allows to study cortical EEG sources in 6239 cortical grey matter voxels.

Materials and methods

Resting EEG was recorded in 20 mild to moderate AD patients (mean age= 75.04 years; 13 women and 7 men; MMSE 15-24) before and after 6 months and 2 years on ChEI (donepezil, rivastigmine, galantamine) treatment. Based on changes of MMSE scores after 2 years follow-up, 11 patients were classified as Non-responders (decrease of MMSE > 2) and 9 patients as Responders (decrease of MMSE < 2). The localization of the differences in activity between two groups (at baseline) and within groups (baseline vs. 6 months) was assessed by voxel-by-voxel t-tests of the sLORETA images of the log-transformed computed current density power in seven frequency bands.


At baseline, Non-responders had significantly greater current densities in delta and alpha frequency band, which sLORETA localized in frontal (BA 6,8,9,32; alpha) and parieto-occipital (BA 7,17,39,40; delta) areas. After 6 months of ChEI treatment only Responders showed an increase of beta current densities, mainly in left frontal and temporal cortex.


Our results suggest that there is a subgroup of AD patients (probably with more pronounced central cholinergic deficiency syndrome) with better response to ChEI treatment, which can be identified by means of new quantitative EEG technique (sLORETA).


The study was supported by a grant from Ministry of Health of Czech Republic No. 1A/8600 - 4.


  1. Pascual-Marqui RD: Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details.

    Methods Find Exp Clin Pharmacol 2002, 24D:5-12. OpenURL